Literature DB >> 17314235

Metformin restores the penile expression of nitric oxide synthase in high-fat-fed obese rats.

Yong-Woon Kim1, So-Young Park, Jong-Yeon Kim, Jung-Yoon Huh, Woo-Sung Jeon, Chang-Jun Yoon, Sung-Su Yun, Ki-Hak Moon.   

Abstract

Obesity is a well-known risk factor for erectile dysfunction, which is associated with reduced penile nitric oxide synthase (NOS) expression. Recently it was reported that metformin activates AMP-activated protein kinase (AMPK), which increases the expression of neuronal (n) NOS and endothelial (e) NOS. Thus, to evaluate whether metformin restores NOS expression in penile tissue, we measured penile expression of nNOS and eNOS after 4 weeks of metformin treatment (300 mg/kg/d) in 5-month-old high-fat-fed obese (HFO) rats. HFO rats have increased fat accumulation in visceral areas and marked suppression of nNOS and eNOS expression in penile tissue. However, metformin treatment decreased visceral fat deposition and restored nNOS and eNOS expression in penile tissue. The levels of AMPK and phosphorylated AMPK were also decreased in HFO rats but were subsequently elevated by metformin treatment. These results suggest that expression of NOS was suppressed by the high-fat diet but restored by metformin treatment. The effect of metformin on the expression of NOS may be associated with its activation of AMPK.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314235     DOI: 10.2164/jandrol.106.001602

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  9 in total

1.  Association between chronic obstructive pulmonary disease and risk of erectile dysfunction: a systematic review and meta-analysis.

Authors:  Lianmin Luo; Shankun Zhao; Jiamin Wang; Yangzhou Liu; Zhiguo Zhu; Qian Xiang; ZhiGang Zhao
Journal:  Int J Impot Res       Date:  2019-07-01       Impact factor: 2.896

2.  Metformin treatment improves erectile function in an angiotensin II model of erectile dysfunction.

Authors:  Hicham Labazi; Brandi M Wynne; Rita Tostes; R Clinton Webb
Journal:  J Sex Med       Date:  2013-07-24       Impact factor: 3.802

3.  Gout is associated with elevated risk of erectile dysfunction: a systematic review and meta-analysis.

Authors:  Lianmin Luo; Qian Xiang; Yihan Deng; Shankun Zhao; Zhiguo Zhu; Yangzhou Liu; Jiamin Wang; Zhigang Zhao
Journal:  Rheumatol Int       Date:  2019-07-05       Impact factor: 2.631

Review 4.  The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth.

Authors:  Sam Amin; Andrew Lux; Finbar O'Callaghan
Journal:  Br J Clin Pharmacol       Date:  2018-11-08       Impact factor: 4.335

5.  Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice.

Authors:  Wilma Helena Oliveira; Clarissa Figueiredo Braga; Deniele Bezerra Lós; Shyrlene Meiry Rocha Araújo; MariaEduarda Rocha França; Eduardo Duarte-Silva; Gabriel Barros Rodrigues; Sura Wanessa Santos Rocha; Christina Alves Peixoto
Journal:  Exp Brain Res       Date:  2021-07-20       Impact factor: 1.972

6.  Macrophage-Specific Toll Like Receptor 9 (TLR9) Causes Corpus Cavernosum Dysfunction in Mice Fed a High Fat Diet.

Authors:  Fernanda Priviero; Fabiano Calmasini; Vanessa Dela Justina; Camilla F Wenceslau; Cameron G McCarthy; R Clinton Webb
Journal:  J Sex Med       Date:  2021-03-16       Impact factor: 3.802

Review 7.  Is there a link between soft drinks and erectile dysfunction?

Authors:  Jan Adamowicz; Tomasz Drewa
Journal:  Cent European J Urol       Date:  2011-09-06

Review 8.  Effects of metformin on endothelial health and erectile dysfunction.

Authors:  Jay Pravin Patel; Eric Hweegeun Lee; Carlos Ignacio Mena; Charles N Walker
Journal:  Transl Androl Urol       Date:  2017-06

Review 9.  Obesity and Erectile Dysfunction: From Bench to Clinical Implication.

Authors:  Ki Hak Moon; So Young Park; Yong Woon Kim
Journal:  World J Mens Health       Date:  2018-07-25       Impact factor: 5.400

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.